Hilz Emily N
University of Texas at Austin, Department of Pharmacy, Division of Pharmacology and Toxicology, 107 W. Dean Keeton St., Austin, TX 78712, United States.
Front Neuroendocrinol. 2022 Jul;66:101011. doi: 10.1016/j.yfrne.2022.101011. Epub 2022 Jun 16.
Hormonal contraceptives (HCs), prescribed to millions of women around the world, alter the ovarian hormonal cycle resulting in neurobehavioral changes in HC users. Human epidemiological and experimental data has characterized some of these effects with oftentimes conflicting or irreproducible results, reflecting a dearth of research considering different compositions, routes of administration, or time-courses of HC use. Non-human animal research can model these effects and help elucidate the underlying mechanisms by which different HCs modulate neurobehavioral outcomes. Still, animal models using HCs are not well-established. This may be because the pharmacological profile of HCs - including the metabolism, receptor binding affinity, and neuromodulatory effects - is dynamic and not always clearly translatable between animals and humans. The current review addresses these issues and provides basic methods and considerations for the use of HCs in animal models of neurobehavior to help advance the field of behavioral neuroendocrinology and inform decisions regarding to women's health.
激素避孕药(HCs)被开给全球数百万女性,它会改变卵巢激素周期,导致使用HCs的女性出现神经行为变化。人类流行病学和实验数据已经对其中一些影响进行了特征描述,但结果往往相互矛盾或无法重复,这反映出在考虑不同成分、给药途径或HCs使用时间过程方面的研究不足。非人类动物研究可以模拟这些影响,并有助于阐明不同HCs调节神经行为结果的潜在机制。然而,使用HCs的动物模型尚未得到很好的确立。这可能是因为HCs的药理学特征——包括代谢、受体结合亲和力和神经调节作用——是动态的,并且在动物和人类之间并不总是能够清楚地转换。本综述探讨了这些问题,并提供了在神经行为动物模型中使用HCs的基本方法和注意事项,以帮助推动行为神经内分泌学领域的发展,并为有关女性健康的决策提供信息。